Amneal Pharmaceuticals
AMRX
#3516
Rank
โ‚น356.50 B
Marketcap
โ‚น1,118
Share price
-1.74%
Change (1 day)
57.79%
Change (1 year)

Revenue for Amneal Pharmaceuticals (AMRX)

Revenue in 2025 (TTM): โ‚น264.33 Billion

According to Amneal Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น284.69 Billion. an increase over the revenue in the year 2024 that were of โ‚น239.68 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amneal Pharmaceuticals from 2018 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น270.99 B13.06%
2024 โ‚น239.68 B20.28%
2023 โ‚น199.26 B8.85%
2022 โ‚น183.06 B17.48%
2021 โ‚น155.83 B6.94%
2020 โ‚น145.72 B25.65%
2019 โ‚น115.97 B-0.26%
2018 โ‚น116.28 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚น60.55 B-78.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น21.31 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA